Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

55.97 +0.07 (+0.13%)
Official Closing Price Updated: 7:00 PM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
38 39 Next >
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Expert Ratings for CVS Health
Via Benzinga
CVS Health Gains Momentum: Analyst Points To Potential 4-Star Medicare Rating
Shares of CVS Health Corp (NYSE: CVS) were trading higher on Tuesday, after attracting short interest earlier in the month. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 19, 2023
Via Benzinga
CVS Health Corp. (NYSE: CVS) Highlighted for Surprising Price Action
Via Investor Brand Network
CVS Health Unusual Options Activity For September 19
Via Benzinga
A Look Into CVS Health Inc's Price Over Earnings
Via Benzinga
2 Top Stocks to Buy Near Their 52-Week Lows
They are down but not out. 
Via The Motley Fool
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37... 
Via Benzinga
2 Beaten-Down Dividend Growth Stocks That Look Like Bargains Now
Buying these dividend growers on the dips could lead to huge passive income streams by the time you're ready to retire. 
Via The Motley Fool
3 Stocks That Could Be Kicked Out of the Dow -- and the Companies That May Replace Them
Three time-tested yet poor-performing Dow components are at risk of being removed from the index. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Stagflationary Moves In Bonds And Oil Opens Golden Opportunity
Is there anything better than stagflationary pressures on gold prices? A weaker dollar and falling interest rates create a sweet spot for gold. 
Via Talk Markets
Looking Into CVS Health's Recent Short Interest
Via Benzinga
Betting With the ‘Big Short’: 3 Michael Burry Stocks to Bank On
Burry's insight and strategic thinking led him to invest in three seemingly disparate industries. 
Via InvestorPlace
3 Strong Sell Stocks for September 2023
These 3 stocks to avoid aren't offering much right now – except uncertainty and massive risk of potential losses. 
Via InvestorPlace
3 S&P 500 Stocks to Sell Before a Crash
Here's a list of S&P 500 stocks to sell. Each has a unique reason behind its bearish thesis, prompting investors to take action. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now 
Via Benzinga
These 3 Health Care Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
Health insurers dramatically mark up prices of generics and pharmacies are in on the scheme. 
Via Talk Markets
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for... 
Via Benzinga
Exposures Product Safety
CVS, Walgreens Boots Among Firms Receiving Warning Letter Against Selling Unapproved Eye Products
The FDA has issued warning letters to eight companies for manufacturing or marketing unapproved ophthalmic drug products violating fed 
Via Benzinga
Exposures Product Safety
It's a Good Time To Buy High-Yield Dogs of the Dividend Kings
These Dividend Kings have been hammered for the last year but now offer value and high yield with a chance for a significant share price rebound. 
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
Via Benzinga
S&P 500: Tesla, Apple Chipmaker Lead Big Movers
Aerospace giant RTX led losers on the benchmark index Monday. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Another Arthritis Blockbuster Drug Faces Generic Competition: Novartis' Sandoz Inks Pact With Samsung Bioepis
Sandoz, a generic and biosimilar medicines unit of Novartis AG (NYSE: NVS), has  
Via Benzinga
Walmart Contemplates Multi-billion Dollar Majority Stake In ChenMed
Walmart Inc. (NYSE: WMT) is reportedly contemplating the  
Via Benzinga
The 3 Best Safe Stocks to Buy Now: September 2023
Buying safe stocks despite the market looking healthy is a wise investment decision because there are still signs a recession could occur. 
Via InvestorPlace
Topics Economy
Exposures Economy
If You'd Invested $25,000 in CVS Health 20 Years Ago, This Is How Much You Would Have Today
Your investment grew nicely, but would investing in CVS have been a better move than simply going with the S&P 500? 
Via The Motley Fool
Topics Stocks
Exposures US Equities
3 Dow Stocks to Sell in September Before They Crash and Burn
Despite the Dow's reputation of consisting of only solid, blue-chip stocks, these three are proving risky and making the list of Dow stocks to sell. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
38 39 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.